The PennZone

  • Home
  • Entertainment
  • Marketing
  • Music
  • Non-profit
  • Books
  • Artificial Intelligence
  • Education
  • Automotive

Good news! The COVID-19 vaccine is coming to Whittier Health Network in Massachusetts
The PennZone/10102000

Trending...
  • Charmaine Thompson Turns Pain Into Purpose Through Woman of Power Charmcare
  • Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
Dr Paul Liguori receiving vaccine Philip Arcidi, Treasurer receiving vaccine Whittier Rehabilitation Hospital
The vaccine will be distributed at the Skilled Nursing Facilities, through a partnership with CVS, on a schedule beginning December 29th, and at our Transitional Care Units starting January 4th.

HAVERHILL, Mass. - PennZone -- Here's what you need to know.

At Whittier Health Network, we are dedicated to the well-being of our patients, residents, and staff, and we care for them just like family. That's why we are making sure the COVID-19 vaccine will be available at all of our facilities now that it is approved by the FDA and is currently being distributed.

We will hold a "vaccine clinic" throughout the Whittier Health Network beginning the last week of December. We urge our employees to sign up—for their safety and for the protection of their families and those they care for here at Whittier.

Our Medical staff will be taking the vaccine including our Medical Directors, Dr. Paul Liguori, MD, MRM at Whittier Rehabilitation Hospital Bradford and Dr. John V. Turchetta at Whittier Rehabilitation Hospital Westborough. Senior management at Whittier will also receive the vaccine to show leadership to staff and to show that the vaccine is safe.

More on The PennZone
  • FindCostSeg Launches Nationwide Directory for Cost Segregation Providers
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
  • Four-Time Olympian Joetta Clark Diggs to Compete at World Masters Athletics Championships in Daegu
  • New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors

The vaccine will be distributed at the Skilled Nursing Facilities, through a partnership with CVS, on a schedule beginning December 29th, and at our Transitional Care Units starting January 4th. Our excellent healthcare staff, patients, and residents take priority and will receive the vaccines first.

A 90% or more adoption rate will significantly reduce outbreaks within each facility. The goal is 100%. It will take many resources to accomplish, but we're up to the task of keeping our family safe.

We also plan to implement CVS's VSafe app, a smartphone-based post-vaccination application that will allow those who have been vaccinated to sign up for monitoring post-vaccine statuses going forward. VSafe incorporates text messages and web surveys and relays information back to the CDC about how those who have been vaccinated are doing post-vaccine.

Visit our blog, where Dr. Paul Liguori at Whittier Rehabilitation Hospital Bradford, explains the vaccine process and how it works within your body: https://hubs.ly/H0CM8cN0.

For more information from the Centers for Disease Control, visit http://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html.

We look forward to the vaccine helping to protect the well-being of our employees, residents and patients.

Contact
Kathy Soderberg - Chief Compliance Officer
***@whittierhealth.com


Source: Whittier Health Network

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • LATO AI Automates Customer Communication to Help CSide Sports Academy and BAT 24 Nation Grow
  • Real Estate Syndication Attorney Tilden Moschetti Releases The Real Estate Private Equity Blueprint
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
  • Tina Hasselbusch, Turnstone Creative Co-founder and Chief Executive Officer, Named to LVB 300
  • Pittsburgh Family Law Attorneys at Pollock Begg Earn Top Honors in 2027 Best Lawyers Guide
  • Independent Colbert Packaging Thrives Amid Industrywide Consolidation
  • Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
  • Slotozilla Reports Strong Growth in Q2 2026
  • Eric Snyder, President and Chief Executive Officer of Keystone Consulting Engineers Named to LVB 300
  • Philadelphia's Girls Anthem to Host The Locker Room Experience Pop-Up for Young Women
  • Flexible Plan Investments Names Carl Resnick President
  • Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
  • Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
  • No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
  • The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma
  • Sharon Pinkenson Chosen as Philly Girl Top 40 Winner
  • Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Charmaine Thompson Turns Pain Into Purpose Through Woman of Power Charmcare

Popular on PennZone

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 670
  • Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments - 107
  • Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH - 101
  • Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
  • Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Board of Directors
  • $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
  • AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
  • Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
  • Charmaine Thompson Turns Pain Into Purpose Through Woman of Power Charmcare
  • Crossroads4Hope Announces The Lipschutz Women's Fund

Similar on PennZone

  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man
  • Independent Colbert Packaging Thrives Amid Industrywide Consolidation
  • No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention
  • Scientific Figure Releases Free Layout Template Libraries for Graphical Abstracts and Research Posters
  • Merger Advancement For Embodied AI Co in Robotic Systems Serving High Value Hospitality, Gaming & Real Estate Sectors: MBody AI Corp. (NAS DAQ: MBAI)
  • synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool
  • Crossroads4Hope Marks 25 Years Ensuring No One Faces Cancer Alone At its Inspiring Hope Gala
  • New Book Calls 'Sense of Belonging' the Missing Link in Student Success
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us